Femasys Partners with SandsRx for Fertility Portfolio

The collaboration integrates specialized pharmacy support into OB/GYN care to assist with fertility treatments.

Updated on Oct. 20, 2026 in Pregnancy

Bold vector editorial illustration showing a medical vial and a small ceramic vase, representing fertility pharmacy integration in modern healthcare.
Femasys has partnered with SandsRx Pharmacy to integrate specialized medication coordination into fertility treatment services for OB/GYN practices in Atlanta. AI Illustration. Upload story photo >

Live Poll

Do you trust fertility treatments performed by your OB/GYN as much as those by fertility specialists?

Femasys has entered a partnership with SandsRx Pharmacy to support its FemaSeed fertility portfolio. The agreement aims to streamline medication coordination and pricing for patients seeking fertility services within OB/GYN practices.

Why it matters

This partnership is designed to help clinical practices better manage the timing of ovulation and treatment. It serves as the initial step in a broader plan by Femasys to establish a nationwide network of specialty pharmacy partnerships.

SandsRx Pharmacy, which was founded in 2013, will provide medication expertise and delivery for the FemaSeed fertility portfolio and related diagnostics.

The players

Femasys

Femasys is a biomedical company headquartered in Atlanta that focuses on developing reproductive health solutions.

SandsRx Pharmacy

SandsRx Pharmacy is a pharmacy provider that specializes in medication management and delivery services for fertility treatments.

The details

The collaboration provides OB/GYN practices with direct access to medication coordination and preferred pricing models. By integrating pharmacy services into the clinic setting, the companies intend to improve the management of fertility treatment timelines for patients.

Timeline

  1. SandsRx Pharmacy was founded in 2013.

  2. The Femasys partnership was announced on October 20, 2026.

Culture Shift

This partnership aligns with the movement to integrate specialty pharmacy services into clinical OB/GYN care settings. It reflects a broader shift toward centralized fertility management that prioritizes clinical convenience and medication adherence for patients.

Patients utilizing FemaSeed products may benefit from improved access to fertility medications and potentially lower out-of-pocket costs through preferred pricing. This partnership could simplify the pharmacy experience by coordinating delivery directly through their OB/GYN clinic.

The takeaway

Patients should consult with their healthcare provider to determine if their specific treatment plan qualifies for the new pharmacy coordination benefits. Streamlining medication logistics through your doctor's office can help reduce the administrative burden of fertility cycles.

Further reading

For more information on the evolving landscape of reproductive care, visit the Pregnancy section.

Live Poll

Do you trust fertility treatments performed by your OB/GYN as much as those by fertility specialists?